SNAPIN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.262600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.298440E-01
Normal-vs-Stage2
2.356800E-01
Normal-vs-Stage3
3.095400E-01
Normal-vs-Stage4
9.280000E-01
Stage1-vs-Stage2
7.667600E-01
Stage1-vs-Stage3
7.430400E-01
Stage1-vs-Stage4
4.061000E-01
Stage2-vs-Stage3
4.763800E-01
Stage2-vs-Stage4
5.637800E-01
Stage3-vs-Stage4
4.526400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.599200E-01
Normal-vs-AfricanAmerican
5.802400E-01
Normal-vs-Asian
7.253600E-01
Caucasian-vs-AfricanAmerican
1.440080E-03
Caucasian-vs-Asian
5.453600E-02
AfricanAmerican-vs-Asian
2.305600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.508150E-01
Normal-vs-Female
3.455200E-01
Male-vs-Female
1.786610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.723700E-02
Normal-vs-Age(41-60Yrs)
2.491200E-01
Normal-vs-Age(61-80Yrs)
2.433600E-01
Normal-vs-Age(81-100Yrs)
1.176160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.831610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.406600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.500760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.609800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.468200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.457000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.325800E-01
Normal-vs-Daily Drinker
8.181600E-02
Normal-vs-Weekly Drinker
4.266000E-01
Normal-vs-Occasional Drinker
4.742600E-01
Normal-vs-Social Drinker
7.340000E-02
Non Drinker-vs-Daily Drinker
4.686600E-01
Non Drinker-vs-Weekly Drinker
4.673800E-01
Non Drinker-vs-Occasional Drinker
2.755600E-01
Non Drinker-vs-Social Drinker
7.230400E-01
Daily Drinker-vs-Weekly Drinker
1.081610E-01
Daily Drinker-vs-Occasional Drinker
3.444300E-02
Daily Drinker-vs-Social Drinker
6.574200E-01
Weekly Drinker-vs-Occasional Drinker
7.684200E-01
Weekly Drinker-vs-Social Drinker
2.198000E-01
Occasional Drinker-vs-Social Drinker
9.062300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.405200E-01
Normal-vs-Grade 2
4.510600E-01
Normal-vs-Grade 3
2.764400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.345900E-02
Grade 1-vs-Grade 3
1.456410E-01
Grade 1-vs-Grade 4
2.405200E-01
Grade 2-vs-Grade 3
8.438600E-01
Grade 2-vs-Grade 4
4.510600E-01
Grade 3-vs-Grade 4
2.764400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.670100E-02
Normal-vs-NonDiabetic
2.838600E-01
Diabetic-vs-NonDiabetic
1.813960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.484600E-01
Normal-vs-NoPancreatitis
1.819590E-01
Pancreatitis-vs-NoPancreatitis
5.056100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.416600E-01
Normal-vs-N1
1.603010E-01
N0-vs-N1
1.074830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.564000E-01
Normal-vs-TP53-NonMutant
3.043200E-01
TP53-Mutant-vs-TP53-NonMutant
4.071900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
